HIGHLIGHTS
- who: Marlene Santos and collaborators from the Centro Investigau00e7u00e3o em Sau00fade Ambiente (CISA), Escola Superior Sau00fade, Instituto Politu00e9cnico do have published the research work: The Impact of BDNF, NTRK2, NGFR, CREB1, GSK3B, AKT, MAPK1, MTOR, PTEN, ARC, and SYN1 Genetic Polymorphisms in Antidepressant Treatment Response Phenotypes, in the Journal: (JOURNAL)
- what: Taking this into consideration, the authors aimed to evaluate the role of BDNF, CREB1, NTRK2, NGFR, ARC, GSK3B, AKT, MAPK1, MTOR, PTEN, and SYN1 genetic polymorphisms in AD treatment phenotypes in a cohort of Portuguese MDD patients. To better understand the correlation between the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.